In Brief: Perkin-Elmer/PerSeptive Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Perkin-Elmer/PerSeptive Biosystems: PE expands its "proteomics" technology portfolio by completing proposed $360 mil. PerSeptive buy, a definitive stock-swap deal for which was announced on Aug. 25 ("The Gray Sheet" Sept. 1, 1997, p. 6). The combination will create a fully integrated technology platform in the field of biomedical research and drug discovery, PE claims...